Survival and risk of recidivism in methadone-dependent patients undergoing liver transplantation

Lawrence U. Liu, Thomas D. Schiano, Nancy Lau, Marian O'Rourke, Albert D. Min, Samuel H. Sigal, Martin Drooker, Henry C. Bodenheimer

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Cirrhosis resulting from hepatitis C virus is presently the most common indication for liver transplantation (OLT) in the United States. A number of U.S. transplant centers require cirrhotics who are using methadone to discontinue it before proceeding with OLT. We sought to examine the outcomes of those patients who had undergone OLT at the Mount Sinai Medical Center. A retrospective chart review of 36 subjects on methadone maintenance treatment (MMT), and off heroin, at the time of OLT was performed. The median daily methadone dose pre-OLT was 50 mg. Post-OLT, there was an increase in methadone dose in 15 subjects, a decrease in four subjects, and no dose change in 17 subjects. Four subjects had documented single episodes of intravenous drug use post-OLT, only one subject had a dose change after the event. Patient and graft survival rates were comparable to the national average. There was no significant difference in post-OLT outcome in patients on MMT when compared with the general population. The few episodes of drug relapse were not related to changes in the methadone dose. Efforts should be made to allow methadone-using cirrhotics better access to OLT without regard to methadone dosage.

Original languageEnglish (US)
Pages (from-to)1273-1277
Number of pages5
JournalAmerican Journal of Transplantation
Volume3
Issue number10
DOIs
StatePublished - Oct 2003
Externally publishedYes

Fingerprint

Methadone
Liver Transplantation
Survival
Heroin
Graft Survival
Hepacivirus
Pharmaceutical Preparations
Fibrosis
Survival Rate
Transplants
Recurrence
Therapeutics
Population

Keywords

  • Liver
  • Methadone
  • Transplantation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Cite this

Survival and risk of recidivism in methadone-dependent patients undergoing liver transplantation. / Liu, Lawrence U.; Schiano, Thomas D.; Lau, Nancy; O'Rourke, Marian; Min, Albert D.; Sigal, Samuel H.; Drooker, Martin; Bodenheimer, Henry C.

In: American Journal of Transplantation, Vol. 3, No. 10, 10.2003, p. 1273-1277.

Research output: Contribution to journalArticle

Liu, Lawrence U. ; Schiano, Thomas D. ; Lau, Nancy ; O'Rourke, Marian ; Min, Albert D. ; Sigal, Samuel H. ; Drooker, Martin ; Bodenheimer, Henry C. / Survival and risk of recidivism in methadone-dependent patients undergoing liver transplantation. In: American Journal of Transplantation. 2003 ; Vol. 3, No. 10. pp. 1273-1277.
@article{6fd9b09080f446cfa574ae89c81d61a8,
title = "Survival and risk of recidivism in methadone-dependent patients undergoing liver transplantation",
abstract = "Cirrhosis resulting from hepatitis C virus is presently the most common indication for liver transplantation (OLT) in the United States. A number of U.S. transplant centers require cirrhotics who are using methadone to discontinue it before proceeding with OLT. We sought to examine the outcomes of those patients who had undergone OLT at the Mount Sinai Medical Center. A retrospective chart review of 36 subjects on methadone maintenance treatment (MMT), and off heroin, at the time of OLT was performed. The median daily methadone dose pre-OLT was 50 mg. Post-OLT, there was an increase in methadone dose in 15 subjects, a decrease in four subjects, and no dose change in 17 subjects. Four subjects had documented single episodes of intravenous drug use post-OLT, only one subject had a dose change after the event. Patient and graft survival rates were comparable to the national average. There was no significant difference in post-OLT outcome in patients on MMT when compared with the general population. The few episodes of drug relapse were not related to changes in the methadone dose. Efforts should be made to allow methadone-using cirrhotics better access to OLT without regard to methadone dosage.",
keywords = "Liver, Methadone, Transplantation",
author = "Liu, {Lawrence U.} and Schiano, {Thomas D.} and Nancy Lau and Marian O'Rourke and Min, {Albert D.} and Sigal, {Samuel H.} and Martin Drooker and Bodenheimer, {Henry C.}",
year = "2003",
month = "10",
doi = "10.1046/j.1600-6143.2003.00199.x",
language = "English (US)",
volume = "3",
pages = "1273--1277",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Survival and risk of recidivism in methadone-dependent patients undergoing liver transplantation

AU - Liu, Lawrence U.

AU - Schiano, Thomas D.

AU - Lau, Nancy

AU - O'Rourke, Marian

AU - Min, Albert D.

AU - Sigal, Samuel H.

AU - Drooker, Martin

AU - Bodenheimer, Henry C.

PY - 2003/10

Y1 - 2003/10

N2 - Cirrhosis resulting from hepatitis C virus is presently the most common indication for liver transplantation (OLT) in the United States. A number of U.S. transplant centers require cirrhotics who are using methadone to discontinue it before proceeding with OLT. We sought to examine the outcomes of those patients who had undergone OLT at the Mount Sinai Medical Center. A retrospective chart review of 36 subjects on methadone maintenance treatment (MMT), and off heroin, at the time of OLT was performed. The median daily methadone dose pre-OLT was 50 mg. Post-OLT, there was an increase in methadone dose in 15 subjects, a decrease in four subjects, and no dose change in 17 subjects. Four subjects had documented single episodes of intravenous drug use post-OLT, only one subject had a dose change after the event. Patient and graft survival rates were comparable to the national average. There was no significant difference in post-OLT outcome in patients on MMT when compared with the general population. The few episodes of drug relapse were not related to changes in the methadone dose. Efforts should be made to allow methadone-using cirrhotics better access to OLT without regard to methadone dosage.

AB - Cirrhosis resulting from hepatitis C virus is presently the most common indication for liver transplantation (OLT) in the United States. A number of U.S. transplant centers require cirrhotics who are using methadone to discontinue it before proceeding with OLT. We sought to examine the outcomes of those patients who had undergone OLT at the Mount Sinai Medical Center. A retrospective chart review of 36 subjects on methadone maintenance treatment (MMT), and off heroin, at the time of OLT was performed. The median daily methadone dose pre-OLT was 50 mg. Post-OLT, there was an increase in methadone dose in 15 subjects, a decrease in four subjects, and no dose change in 17 subjects. Four subjects had documented single episodes of intravenous drug use post-OLT, only one subject had a dose change after the event. Patient and graft survival rates were comparable to the national average. There was no significant difference in post-OLT outcome in patients on MMT when compared with the general population. The few episodes of drug relapse were not related to changes in the methadone dose. Efforts should be made to allow methadone-using cirrhotics better access to OLT without regard to methadone dosage.

KW - Liver

KW - Methadone

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=0141669248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141669248&partnerID=8YFLogxK

U2 - 10.1046/j.1600-6143.2003.00199.x

DO - 10.1046/j.1600-6143.2003.00199.x

M3 - Article

C2 - 14510701

AN - SCOPUS:0141669248

VL - 3

SP - 1273

EP - 1277

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 10

ER -